$3.35
0.05 (+1.52%)
DepoMed, Inc. (DEPO)
CAPS Rating:
A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

RSS Headlines
Fool UK